Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mohammed L Ibrahim

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|May 13, 2018
IFNAR1 Controls Autocrine Type I IFN Regulation of PD-L1 Expression in Myeloid-Derived Suppressor CellsWei Xiao, John D Klement, Chunwan Lu, et al.
Bioorganic Chemistry|June 19, 2024
Design, synthesis, antineoplastic activity of new pyrazolo[3,4-d]pyrimidine derivatives as dual CDK2/GSK3β kinase inhibitors; molecular docking study, and ADME predictionMohamed T M Nemr, Ahmed Elshewy, Mohammed L Ibrahim, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 3, 2024
Histone Deacetylase Inhibitors Directly Modulate T Cell Gene Expression and Signaling and Promote Development of Effector-Exhausted T Cells in Murine TumorsMohammed L Ibrahim, Hong Zheng, Margaret L Barlow, et al.
Cancer Immunology, Immunotherapy : CII|June 4, 2020
Expression profiles and function of IL6 in polymorphonuclear myeloid-derived suppressor cellsMohammed L Ibrahim, Chunwan Lu, John D Klement, et al.
Oncoimmunology|September 20, 2018
H3K4me3 mediates the NF-κB p50 homodimer binding to the <i>pdcd1</i> promoter to activate PD-1 transcription in T cellsPriscilla S Redd, Chunwan Lu, John D Klement, et al.
Journal for Immunotherapy of Cancer|June 24, 2019
Type I interferon suppresses tumor growth through activating the STAT3-granzyme B pathway in tumor-infiltrating cytotoxic T lymphocytesChunwan Lu, John D Klement, Mohammed L Ibrahim, et al.
Molecular Cancer Research : MCR|November 16, 2018
Loss of Fas Expression and Function Is Coupled with Colon Cancer Resistance to Immune Checkpoint Inhibitor ImmunotherapyWei Xiao, Mohammed L Ibrahim, Priscilla S Redd, et al.
Cancer Research|April 7, 2017
SETD1B Activates iNOS Expression in Myeloid-Derived Suppressor CellsPriscilla S Redd, Mohammed L Ibrahim, John D Klement, et al.
The Journal of Clinical Investigation|November 6, 2018
An osteopontin/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasionJohn D Klement, Amy V Paschall, Priscilla S Redd, et al.
Cell Reports|December 13, 2018
Myeloid-Derived Suppressor Cells Produce IL-10 to Elicit DNMT3b-Dependent IRF8 Silencing to Promote Colitis-Associated Colon TumorigenesisMohammed L Ibrahim, John D Klement, Chunwan Lu, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Journal of Immunology (Baltimore, Md. : 1950)|May 13, 2018
IFNAR1 Controls Autocrine Type I IFN Regulation of PD-L1 Expression in Myeloid-Derived Suppressor CellsWei Xiao, John D Klement, Chunwan Lu, et al.
Bioorganic Chemistry|June 19, 2024
Design, synthesis, antineoplastic activity of new pyrazolo[3,4-d]pyrimidine derivatives as dual CDK2/GSK3β kinase inhibitors; molecular docking study, and ADME predictionMohamed T M Nemr, Ahmed Elshewy, Mohammed L Ibrahim, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 3, 2024
Histone Deacetylase Inhibitors Directly Modulate T Cell Gene Expression and Signaling and Promote Development of Effector-Exhausted T Cells in Murine TumorsMohammed L Ibrahim, Hong Zheng, Margaret L Barlow, et al.
Cancer Immunology, Immunotherapy : CII|June 4, 2020
Expression profiles and function of IL6 in polymorphonuclear myeloid-derived suppressor cellsMohammed L Ibrahim, Chunwan Lu, John D Klement, et al.
Oncoimmunology|September 20, 2018
H3K4me3 mediates the NF-κB p50 homodimer binding to the <i>pdcd1</i> promoter to activate PD-1 transcription in T cellsPriscilla S Redd, Chunwan Lu, John D Klement, et al.
Journal for Immunotherapy of Cancer|June 24, 2019
Type I interferon suppresses tumor growth through activating the STAT3-granzyme B pathway in tumor-infiltrating cytotoxic T lymphocytesChunwan Lu, John D Klement, Mohammed L Ibrahim, et al.
Molecular Cancer Research : MCR|November 16, 2018
Loss of Fas Expression and Function Is Coupled with Colon Cancer Resistance to Immune Checkpoint Inhibitor ImmunotherapyWei Xiao, Mohammed L Ibrahim, Priscilla S Redd, et al.
Cancer Research|April 7, 2017
SETD1B Activates iNOS Expression in Myeloid-Derived Suppressor CellsPriscilla S Redd, Mohammed L Ibrahim, John D Klement, et al.
The Journal of Clinical Investigation|November 6, 2018
An osteopontin/CD44 immune checkpoint controls CD8+ T cell activation and tumor immune evasionJohn D Klement, Amy V Paschall, Priscilla S Redd, et al.
Cell Reports|December 13, 2018
Myeloid-Derived Suppressor Cells Produce IL-10 to Elicit DNMT3b-Dependent IRF8 Silencing to Promote Colitis-Associated Colon TumorigenesisMohammed L Ibrahim, John D Klement, Chunwan Lu, et al.
Pageof 2